metabolic syndrome (MS)
Conditions
Interventions
Treatment group:Conventional western medicine treatment + Huanglian Wendan decoction
Control group:Conventional western medicine treatment
Health group:None
Sponsors
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. No gender limit, aged between 30 and 75 years. 2. In line with the Western diagnostic standards for MS and the TCM phlegm-heat stasis syndrome differentiation standards, and in line with the medication plan. 3. Fully understand the nature, purpose and content of the clinical trial, participate voluntarily, and sign the informed consent. 4. Previous treatment with other traditional Chinese medicine, after 1 month washout period.
Exclusion criteria
Exclusion criteria: 1. Patients with malignant tumors, organ failure, transplantation and other serious chronic diseases. 2. Long-term use of thyroid medications, steroids and estrogen. 3. Patients with uncontrolled hypertension (SBP>=180 and/or DBP>=110), severe cardiopulmonary insufficiency, severe arrhythmias (rapid atrial fibrillation, atrial flutter, paroxysmal ventricular tachycardia, etc., sinus arrest, sinus bradycardia, sick sinus syndrome, complete bundle branch block), and the acute phase of other serious diseases. 4. Severely infected persons who have not been effectively controlled. 5. Patients with uncontrolled hyperglycemia and severe complications of diabetes. 6. Familial refractory hyperlipidemia. 7. Patients with abnormal liver function (ALT/AST > 1.5 times of normal value), abnormal kidney function (Cr > 1.5 times of normal value), severe damage to hematopoietic and autoimmune systems. 8. Pregnant and lactating patients and those who have fertility requirements within 3 months. 9. Patients with disabilities defined by law who are blind, deaf, mute, physically disabled, mentally retarded, or unable to express subjective symptoms of discomfort. 10. Suspected or confirmed history of alcohol and drug abuse. 11. Patients who are allergic, or allergic to more than three kinds of food or drugs. 12. Patients who have participated in clinical studies of other drugs or are using other traditional Chinese medicine products within the last 1 month. 13. Patients unable to receive regular follow-up. 14. Any other factors affecting test results and data acquisition and accuracy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure (systolic and diastolic);Blood fat (high-density lipoprotein, triglyceride);Fasting blood-glucose;Waistline; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese medicine syndrome score; | — |
Countries
China
Contacts
Public ContactTang Yue (tutor: Liu Li)
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Outcome results
None listed